Toxicities and response rate in stage II non-small cell lung cancer patients receiving paclitaxel-cisplatin - One-year observational study
Keyword(s):
Keyword(s):
2020 ◽
Vol 1
(2)
◽
pp. 94-98
◽
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. e20572-e20572
◽
Keyword(s):
2020 ◽
Vol 18
(3.5)
◽
pp. HSR20-101
Keyword(s):
Keyword(s):
Keyword(s):